Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
FULC
#4057
Fulcrum Therapeutics, Inc. Common Stock
8.3
8
-3.68%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-3.68%
Changement Mensuel
-23.26%
Evolution sur 6 mois
+25.26%
Changement Annuel
+145.75%
Clôture Précédente
8.7
0
Open
8.3
8
Bid
Ask
Low
8.3
8
High
8.3
8
Volume
82
Marchés
Actions des Marchés US
Soins de Santé
FULC
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
32.67 M
40.64 M
61.76 M
61.94 M
53.98 M
66.6 M
—
Valuation ratios
Enterprise value
325.54 M
683.46 M
452.8 M
420.99 M
195.49 M
555.72 M
1.45 B
Price to earnings ratio
—
—
-3.24
-4.53
-29.38
-9.58
-4.91
Price to sales ratio
—
—
0.06
0.16
0
—
—
Price to cash flow ratio
—
—
0
0
0.13
0.01
-0.06
Price to book ratio
—
—
0
0
0
0
0.01
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.55
0.34
0.48
0.38
0.04
0.2
0.3
Return on equity %
0.74
0.38
0.55
0.41
0.04
0.21
0.31
Return on invested capital %
694.39
255.15
242.06
217.3
41.52
188.47
—
Gross margin %
100
100
100
100
100
—
—
Operating margin %
811.64
422.97
1 774.85
3 945.24
27.37
—
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
802.66
421.89
1 732.43
3 470.05
12.16
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
4.47
11.77
12.41
17.71
22.63
27.4
98.22
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.07
0.11
0.03
0.01
0.31
0
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
2 157.1
1 483.69
35.78
948.07
270.23
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
780.11
416.95
939.15
3 117.88
3 133.39
Net current asset value per share
—
—
4 612.46
3 950.4
4 032.06
5 642.49
5 719.88
Tangible book value per share
—
—
4 421.82
3 836.13
3 920.92
5 508.64
15.76 K
Working capital per share
—
—
4 240.71
3 727.35
3 853.88
5 436.54
5 510.55
Book value per share
—
—
4 421.82
3 836.13
3 920.92
5 508.64
5 584.08
Nouvelles
Fulcrum: Strong HbF Signal, Narrow TAM, Same 'Hold' Conclusion (NASDAQ:FULC)
Le titre Fulcrum Therapeutics chute après l’échec d’un essai clinique
Fulcrum Therapeutics stock falls as sickle cell trial misses target
Leerink réitère sa recommandation sur Fulcrum Therapeutics après les données sur la drépanocytose
Leerink reiterates Fulcrum Therapeutics stock rating on SCD data
BofA réitère sa note Sous-performance sur Fulcrum Therapeutics à 7$
BofA reiterates Fulcrum Therapeutics stock Underperform rating at $7
Qu'est-ce qui se passe avec l'action de Fulcrum Therapeutics mardi? | Benzinga France
Stifel réitère sa recommandation sur Fulcrum Therapeutics après des données cliniques
Stifel reiterates Fulcrum Therapeutics stock rating on drug data
Les actions de Fulcrum Therapeutics chutent sur fond de prises de bénéfices
Fulcrum Therapeutics shares fall on profit-taking, Oppenheimer says